Famous Insider Trading Cases: What Actually Happened (and What Was Actually Illegal)

Search "famous insider trading cases" and you'll get a mix of household names, prison sentences, and headlines that rarely explain the actual mechanics of what happened. The cases are worth understanding for their own sake — they're the reason the current disclosure rules exist — but they're also a useful contrast to what most people mean when they say "insider trading" today, which is usually nothing more than a routine, legal Form 4 filing.

Here's what actually happened in a handful of the most cited cases, and the legal principle each one illustrates.

A Quick Reminder of What Makes It Illegal

Illegal insider trading requires trading a security while in possession of material, non-public information, in breach of a duty of trust. We cover the full legal test in our piece on the definition and legal framework — the short version is that materiality, non-public status, and a breach of duty all have to be present at once. The cases below are useful precisely because each one shows a different way that test got satisfied — and a different way regulators proved it.

Ivan Boesky: The Arbitrageur and the Information Network

Ivan Boesky was a Wall Street arbitrageur in the 1980s who built a reputation for uncannily well-timed bets on companies that were about to become takeover targets. The pattern regulators eventually pieced together was that Boesky was paying for advance word of pending mergers and acquisitions from investment bankers and other insiders who had access to deal information before it became public — then trading ahead of the announcements.

Boesky's case became one of the signature prosecutions of the decade and helped establish, in the public imagination as much as in case law, the idea of an information network: insiders leaking deal information not out of carelessness but for direct payment, feeding traders who then profited on confirmation of the leak. The general shape of the case — paying sources for advance knowledge of unannounced M&A activity — is the same pattern regulators still look for today whenever a stock moves sharply just ahead of a deal announcement.

Martha Stewart and ImClone: Tipper, Tippee, and a Broker in the Middle

The Martha Stewart case is probably the most widely recognized name attached to an insider trading scandal, and it's also one of the most commonly misunderstood. Stewart was not charged with insider trading in the way most people assume.

The underlying allegation involved ImClone Systems, a biotech company. Word that a regulatory decision was going to go badly for the company circulated among people connected to its founder before it became public. Stewart sold her ImClone shares after receiving information — relayed through her broker, who also handled the ImClone founder's account — that suggested insiders were exiting the stock. She was investigated for the trade itself, but her eventual conviction centered on charges related to obstruction and false statements made to investigators about the circumstances of the sale, not a securities fraud conviction for the trade itself.

The case is a useful illustration of tippee liability: the idea that you don't have to be a corporate insider yourself to face legal exposure. If you receive material, non-public information from someone who breached a duty in sharing it, and you knew or should have known that, trading on it can create liability for you too — and how you handle the aftermath, including what you tell investigators, can become its own legal problem entirely.

Raj Rajaratnam and Galleon Group: The Modern Tippee Network

The Galleon Group case, centered on hedge fund manager Raj Rajaratnam, is generally regarded as one of the largest insider trading prosecutions in terms of scope. Rajaratnam and his fund were found to have built a network of contacts — including corporate executives and, notably, at least one board-level source with insight into major deal activity — who fed him advance, non-public information on earnings results and pending corporate transactions across multiple companies.

What made the case notable beyond its scale was the investigative method: prosecutors leaned heavily on wiretaps, a technique more associated with organized crime and narcotics cases than white-collar securities fraud. That approach reflected how seriously regulators and the DOJ had come to treat coordinated insider trading networks, and it produced some of the most direct, unambiguous evidence ever presented in a case of this kind. Rajaratnam was convicted on multiple counts and the case remains a reference point for how tippee chains — insider to tipper to trader — get prosecuted when there are several links.

Enron and the Financial-Statement-Fraud Adjacent Cases

The Enron collapse in the early 2000s is usually remembered as an accounting fraud story, and at its core it was — the company used off-balance-sheet structures to hide losses and inflate reported performance. But the scandal also produced insider trading allegations, because some executives and insiders who knew the true financial condition of the company sold shares before the fraud became public and the stock collapsed.

Enron-era cases illustrate a related but distinct principle: trading ahead of a collapse you have inside knowledge of is just as much a violation as trading ahead of good news. Materiality doesn't discriminate between information that would make a stock go up or down — an insider who sells not-yet-public bad news to the market by exiting before everyone else can face exactly the same theory of liability as one who buys ahead of not-yet-public good news.

SAC Capital and the Expert Network Cases

A separate wave of cases in the early 2010s centered on so-called "expert network" arrangements, where hedge funds paid consultants — often doctors, scientists, or former employees — for insight into specific companies or industries. In several prosecutions, regulators alleged that some of these consultants crossed the line from offering general industry expertise into passing along specific, non-public details, such as unreleased clinical trial results or unannounced earnings figures, that fund traders then acted on.

The hedge fund SAC Capital Advisors became closely associated with this era after a portfolio manager was convicted in a case involving trading ahead of the disclosure of unfavorable clinical trial results for an Alzheimer's drug, and the firm itself resolved related civil and criminal matters. The broader expert-network wave illustrates a more modern variation on tippee liability: the information doesn't have to come from inside the company at all. It can come from any source with legitimate access to material non-public details — a scientist on a drug trial's data safety board, a hospital employee with early sales data — provided the trader knew or should have known the information was both material and obtained improperly.

What These Cases Have in Common With Modern Enforcement

It's worth noting that the tools regulators use haven't stood still. Modern insider trading investigations increasingly start with automated market surveillance — software that flags trading volume or options activity that correlates statistically with news that hasn't happened yet — rather than the informant-driven investigations that cracked open cases like Boesky's. We cover how that detection process actually works, including the roles of the SEC, FINRA, and the DOJ, in our piece on who investigates insider trading.

The Common Thread

Strip away the specifics and every one of these cases involves the same structure: someone with access to material information that hadn't reached the market yet, a duty (as an employee, executive, or someone who received a tip) not to trade on it or pass it along improperly, and a trade executed in that window before the information became public. The differences are in scale, method of proof, and how the case was ultimately charged — but the legal test is consistent.

Why This Is a Different Conversation Than "Insider Buying" Today

None of this has much to do with what dominates the "insider trading" conversation in financial media and on tracking sites today. When you see a headline about "insider buying" at a public company, it's almost always referring to a Form 4 filing — a routine, legally required disclosure that a corporate officer, director, or major shareholder made a trade, filed with the SEC typically within two business days. There's no MNPI, no breach of duty, no tip — just a company insider using their own money and disclosing it exactly as the law requires.

That's precisely the version of insider activity that's actually useful as an investing signal, because it's public, verifiable, and timely. It's also the version MySmarTrend's insider trading tracker is built on — a live feed of officer and director transactions pulled directly from SEC filings, so you can see where company insiders are putting their own money to work without wading through EDGAR yourself.

The famous cases above are worth knowing because they're the reason disclosure rules exist in the first place, and because understanding what actually crosses the line helps you understand why the disclosed version doesn't. They're historical enforcement actions, not a preview of what shows up in a modern insider trading feed.

We track real, disclosed insider buying and selling every day — the legal kind that's actually useful as a signal. Free. Drop your email below.